Nazara Technologies Limited will conduct a virtual analyst meeting on June 26, 2026, to discuss its performance based on publicly available information. The interaction is scheduled to begin at 1:00 PM IST and will be held virtually. This meeting provides a platform for the company to engage directly with market participants regarding its operational updates and financial standing.

The session is designated as a one-on-one meeting with Eternalis Capital. The company has notified the stock exchanges regarding this schedule in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The details of the meeting are outlined in the table below:

Discussions during the meeting will rely solely on publicly available information. The company reserves the right to alter the schedule due to exigencies on the part of the participants or the company.

Nazara Technologies Ltd has extended the indicative timeline for infusing funds into its wholly owned subsidiary, Nazara Technologies UK Limited, to August 14, 2026. The company plans to invest a total amount not exceeding USD 100.3 million through equity subscription and loans, as per a disclosure to the exchanges.

The proposed capital infusion is divided into two parts. The company will subscribe to equity shares for an amount not exceeding USD 40.1 million. Additionally, it will provide a loan not exceeding USD 60.2 million to the subsidiary. This update relates to a disclosure originally made on March 18, 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Breakdown of Fund Infusion

The funds will be disbursed in one or more tranches, subject to compliance with applicable laws. Nazara Technologies UK Limited remains a wholly owned subsidiary of the company.